Metabolism and lack of DNA reactivity of the mycotoxin ochratoxin A in cultured rat and human primary hepatocytes

被引:71
作者
Gross-Steinmeyer, K
Weymann, J
Hege, HG
Metzler, M
机构
[1] Knoll GMBH, Drug Metab & Pharmacokinet, D-67008 Ludwigshafen, Germany
[2] Univ Karlsruhe, Inst Food Chem & Toxicol, D-76128 Karlsruhe, Germany
关键词
ochratoxin A; metabolism; covalent DNA binding; hepatocytes; human;
D O I
10.1021/jf0111817
中图分类号
S [农业科学];
学科分类号
09 ;
摘要
It is still unclear whether the carcinogenic mycotoxin ochratoxin A (OTA) is bioactivated to DNA-binding metabolites in rodents and humans. Therefore, we have incubated cultured rat and human primary hepatocytes with noncytotoxic concentrations of H-3-OTA ranging from 10(-7) to 10(-5) M for 8 h and determined its metabolism and covalent DNA binding. In rat hepatocytes, OTA was metabolized to small amounts of three products, which were further studied by electrospray ionization (ESI)-MS/MS techniques. In addition to 4-hydroxy-OTA, which is a known product of OTA biotransformation, two novel metabolites were detected and tentatively identified as hexose and pentose conjugates of OTA. The in vitro induction with 3-methylcholanthrene (3MC) increased the formation of 4-hydroxy-OTA but did not alter the formation of the conjugated metabolites. No covalent binding of 3H-OTA or its metabolites to DNA was observed in rat hepatocytes with or without 3MC induction with a limit of detection of 2 adducts per 10(9) nucleotides. However, the cellular ratio of reduced glutathione to oxidized glutathione was significantly decreased by treatment with OTA. In cultured human hepatocytes, H-3-OTA was only very poorly metabolized, and no covalent DNA binding was observed. In conclusion, the results of this in vitro study do not support the notion that OTA has the potential to undergo metabolic activation and form covalent DNA adducts in rodents and humans.
引用
收藏
页码:938 / 945
页数:8
相关论文
共 77 条
[1]  
[Anonymous], 1993, IARC MON EV CARC RIS
[2]   STEREOSELECTIVE ACYL GLUCURONIDATION AND GLUCOSIDATION OF PRANOPROFEN, A 2-ARYLPROPIONIC ACID-DERIVATIVE, IN MICE INVIVO [J].
ARIMA, N .
JOURNAL OF PHARMACOBIO-DYNAMICS, 1990, 13 (12) :733-738
[3]   ACYL GLUCURONIDATION AND GLUCOSIDATION OF PRANOPROFEN, A 2-ARYLPROPIONIC ACID-DERIVATIVE, IN MOUSE-LIVER AND KIDNEY HOMOGENATES [J].
ARIMA, N .
JOURNAL OF PHARMACOBIO-DYNAMICS, 1990, 13 (12) :724-732
[4]   EVALUATION OF THE GENOTOXIC ACTIVITY OF SOME MYCOTOXINS USING ESCHERICHIA-COLI IN THE SOS SPOT-TEST [J].
AUFFRAY, Y ;
BOUTIBONNES, P .
MUTATION RESEARCH, 1986, 171 (2-3) :79-82
[5]   EVALUATION OF OCHRATOXIN-A FOR MUTAGENICITY IN A BATTERY OF BACTERIAL AND MAMMALIAN-CELL ASSAYS [J].
BENDELE, AM ;
NEAL, SB ;
OBERLY, TJ ;
THOMPSON, CZ ;
BEWSEY, BJ ;
HILL, LE ;
REXROAT, MA ;
CARLTON, WW ;
PROBST, GS .
FOOD AND CHEMICAL TOXICOLOGY, 1985, 23 (10) :911-918
[6]  
BENDELE AM, 1985, J NATL CANCER I, V75, P733
[7]  
Bergmeger HU, 1983, Methods of Enzymatic Analy, V3rd, P118
[8]   RAPID AND SIMPLE METHOD FOR PURIFICATION OF NUCLEIC-ACIDS [J].
BOOM, R ;
SOL, CJA ;
SALIMANS, MMM ;
JANSEN, CL ;
WERTHEIMVANDILLEN, PME ;
VANDERNOORDAA, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (03) :495-503
[9]  
BOORMAN G, 1989, NIH892813 US DEP HLT, P1
[10]  
BOTSCH S, 1993, MOL PHARMACOL, V43, P120